Page last updated: 2024-08-18

ethyl stearate and Parkinson Disease, Secondary

ethyl stearate has been researched along with Parkinson Disease, Secondary in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, D; Chen, L; Huang, J; Li, C; Li, H; Li, X; Lv, J; Miao, J; Ye, S; Yi, L; Zhong, J1

Other Studies

1 other study(ies) available for ethyl stearate and Parkinson Disease, Secondary

ArticleYear
Protective effect of plastrum testudinis extract on dopaminergic neurons in a Parkinson's disease model through DNMT1 nuclear translocation and SNCA's methylation.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021, Volume: 141

    Topics: alpha-Synuclein; Animals; Antiparkinson Agents; DNA (Cytosine-5-)-Methyltransferase 1; Dopaminergic Neurons; Hydroxydopamines; Male; Mesencephalon; Neuroprotective Agents; Parkinson Disease, Secondary; PC12 Cells; Plant Extracts; Rats; Rats, Sprague-Dawley; Stearates; Substantia Nigra; Tissue Extracts

2021